Market Commentary - Stock Alert
Stocks to Watch: Wipro, Hero MotoCorp, NTPC, Vedanta and others As on : 05-Jun-23  08:27

Wipro: Wipro has fixed 16 June 2023 as the Record Date for the purpose of determining the entitlement and the names of equity shareholders who are eligible to participate in the buyback of equity shares by the company.

Hero MotoCorp: Hero MotoCorp launched a new range of its popular 100cc motorcycle - the HF Deluxe. Retaining the brand DNA, the new HF Deluxe portfolio presents the right balance of style, tech-excellence, and performance.

NTPC: NTPC said that its subsidiary, NTPC Green Energy has declared commercial operation of fifth and last part capacity of 50 megawatt (MW) out of 300 MW Nokhra Solar PV project at Bikaner, Rajasthan.

Vedanta: Vedanta announced that its subsidiary, Bharat Aluminium Company (BALCO) has entered into a power delivery agreement (PDA) through special purpose vehicle (SPV), Serentica Renewables India (SRIPL).

Tata Chemicals (TCL): TCL informed that CRISIL Ratings has reaffirmed its 'CRISIL A1+' rating on the commercial paper programme of the company.

SBI Life Insurance Company: The company will take over the policy liabilities of around two lakh policies of Sahara India Life Insurance Company (SILIC), backed by the policyholders' assets, with immediate effect.

Godrej Properties: Godrej Properties said that it has increased its stake in Godrej Home Constructions (GHCL) from 74% to 100% for cash consideration of Rs 14.98 crore.

Lupin: Lupin announced the launch of Darunavir Tablets, 600 mg and 800 mg, to market a generic equivalent of Prezista Tablets of Janssen Products, LP. Darunavir Tablets, 600 mg and 800 mg (RLD Prezista) had estimated annual sales of $308 million in the U.S. (IQVIA MAT March 2023).

Zydus Lifesciences: Zydus Lifesciences said that it has received nil observations for inspection conducted by US Food and Drug Administration (USFDA) at group's animal health drug manufacturing facility at SEZ, Ahmedabad.

Indoco Remedies: Indoco Remedies said that the United States Food and Drug Administration (US FDA) has classified the inspection conducted at its Goa plant II in the February 2023 as OAI (Official Action Indicated).

Minda Corporation: Minda Corporation said that its board has approved the proposal of raising of funds via issue of securities, for an aggregate amount not exceeding Rs 600 crore.

Powered by Capital Market - Live News